SK Capital Announces Promotion and Addition to Team

NEW YORK--(BUSINESS WIRE)-- SK Capital Partners, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, announced today that Stephen d’Incelli has been promoted to Managing Director and Lee Karras has joined as a Director.

Previously a Principal at SK Capital, Mr. d’Incelli has played a significant role in sourcing and executing acquisitions as well as guiding portfolio companies where he serves as a member of numerous Boards of Directors. Prior to joining SK Capital in 2015, Mr. d’Incelli was a Vice President at Sun Capital Partners where he was involved in a variety of acquisitions including corporate carve-outs, entrepreneurial transitions and add-on acquisitions. Before joining Sun Capital, he worked in the Global Leveraged Finance group at Lehman Brothers.

Mr. Karras recently joined SK Capital as a Director where he will be providing guidance to SK Capital portfolio companies in the pharmaceuticals sector as well as helping find and evaluate new investment opportunities.

Mr. Karras has spent the past seven years running SK Capital portfolio companies, most recently in highly successful roles serving as CEO of Halo Pharmaceuticals Inc, and previously as President of IBA Molecular North America. Prior to IBA Molecular, Mr. Karras was President and CEO of AAIPharma Services Company where he led the company’s transition from bankruptcy to a successful exit in 2009. Prior to AAI, Mr. Karras held various positions at Baxter Healthcare and Cook Medical where he served as General Manager and helped build the pharmaceutical services start up into a sizable sterile injectable pharma services business.

About SK Capital

SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and pharmaceuticals sectors. The firm seeks to build strong and growing businesses that create substantial long-term value. SK Capital utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth and profitability as well as lower operating risk. For more information, please visit www.skcapitalpartners.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190313005112/en/

Caroline Collins
BackBay Communications
617-963-0065
[email protected]

Source: SK Capital Partners

You May Also Be Interested In

• Lucid shares pare losses after rebuffing bankruptcy rumors
• E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million C
• Half-Year 2026 Financial Report available